China’s pharmaceutical sector is driven primarily by domestic consumption, policy support and reform, making it attractive for investors. Photo: Shutterstock China’s pharmaceutical sector is driven primarily by domestic consumption, policy support and reform, making it attractive for investors. Photo: Shutterstock
China’s pharmaceutical sector is driven primarily by domestic consumption, policy support and reform, making it attractive for investors. Photo: Shutterstock
Pharmaceuticals

Looking for trade war-proof stock ideas? China’s large pharma firms might be good medicine for investors’ portfolios, analysts say

  • Chinese Big Pharma firms benefiting from policies speeding up drug approvals, incentivising discovery of new medicines
  • Sector primarily driven by domestic consumption, which can help it weather the trade war

Topic |   Pharmaceuticals
China’s pharmaceutical sector is driven primarily by domestic consumption, policy support and reform, making it attractive for investors. Photo: Shutterstock China’s pharmaceutical sector is driven primarily by domestic consumption, policy support and reform, making it attractive for investors. Photo: Shutterstock
China’s pharmaceutical sector is driven primarily by domestic consumption, policy support and reform, making it attractive for investors. Photo: Shutterstock
READ FULL ARTICLE